Navigation Links
ARISTOTLE trial finds new drug may revolutionize the treatment of atrial fibrillation
Date:10/25/2011

Vancouver New research has the potential to revolutionize the treatment of atrial fibrillation (AF), a condition affecting a quarter of a million Canadians which is expected to strike even more in the coming years, as the Canadian population ages.

AF is the most common type of heart arrhythmia and puts those affected at a three to five times greater risk for stroke. Now, there is a new drug poised to battle the condition.

"The majority of patients with atrial fibrillation need an anticoagulant. The current anticoagulant can be a burden for physicians and patients due to its side effects and narrow therapeutic range," Dr. Justin Ezekowitz, from the University of Alberta, told a late breaking clinical trial session at the Canadian Cardiovascular Congress 2011, co-hosted by the Heart and Stroke Foundation of Canada and the Canadian Cardiovascular Congress. It is associated with a risk of bleeding and needs very close monitoring, whereas this new drug is taken twice a day and does not require monitoring. Our trial also shows it is not just equivalent, but better than warfarin for preventing strokes. These are important advantages."

The mainstay of treatment for AF, in which the heart's rhythm becomes very irregular and rapid, has been warfarin, an anticoagulant which has been highly effective in preventing stroke in patients with AF. However, it requires patients to come in to their doctor's office for frequent blood tests, is associated with bleeding, and it also can interact with a variety of foods and drugs that patients might also be taking. Apixaban, a new type of oral anticoagulant known as a factor Xa inhibitor, resulted in fewer strokes (ischemic or hemorrhagic) and fewer systemic embolisms, caused less bleeding and resulted in fewer deaths in patients with atrial fibrillation, said Dr. Ezekowitz.

"We have a drug that can increase reductions in death and stroke and it is safer in terms of bleeding," says Dr. Ezekowi
'/>"/>

Contact: Amanda Bates
amanda@curvecommunications.com
604-306-0027
Heart and Stroke Foundation of Canada
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. HIV Medication Patch Shows Promise in Early Trial
2. Weight Gain Might Raise Endometrial Cancer Risk
3. Significant weight gain in adulthood increased risk for endometrial cancer
4. Timing for clinical trials for stem cell therapy in spinal cord injuries is right
5. Penn-developed online informed consent tool could boost number of patients in cancer clinical trials
6. Major HIV prevention trial in women to drop oral tenofovir arm
7. Company stock prices before public announcements of oncology trial results
8. Smaller, faster trials can improve cancer patient survival
9. Abiraterone acetate improves fatigue in prostate cancer patients, says international clinical trial
10. First Phase III trial of an alpha-pharmaceutical
11. TGen-Virginia G. Piper Cancer Center launches clinical trial for drug to treat lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... (PRWEB) September 02, 2014 Cloud Medical ... of “Cloud Based” Medical Practice Business Operations solutions and ... of Digital Cyber Security solutions for all industries announced ... on the trading floor of the CME in Chicago ... DeLaGarza stated that we are very proud of the ...
(Date:9/2/2014)... NY (PRWEB) September 02, 2014 The ... new blood thinners is growing at a rapid pace, ... to mount in courts around the U.S., Bernstein Liebhard ... American Journal of Medicine, within a year of its ... prescribed Xarelto as warfarin, a blood thinner that has ...
(Date:9/2/2014)... 2014 The Wm. Jennings Bryan Dorn Veterans ... town hall meeting for Veterans and their families on September ... fair to provide Veterans with valuable healthcare and benefit information,” ... will provide a forum where we can gather important input ... outreach fair will be held 4:45 p.m. to 5:45 p.m. ...
(Date:9/2/2014)... September 02, 2014 On August 30, ... website titled “Why You Should Wash Your Face ... of the global population breathes air considered polluted by ... pollution lodge in the skin’s pores destroying its natural ... to free radicals that may cause cell damage, redness, ...
(Date:9/2/2014)... 2014 (HealthDay News) -- Complications are rare among ... a new study indicates. However, the researchers ... with a slightly higher risk for certain complications ... more than 18,000 breast cancer patients who had ... with breast reconstruction and were followed for 30 ...
Breaking Medicine News(10 mins):Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 2Health News:Cloud Medical Doctor Software Corporation's CEO Interviewed by the Price Futures Group 3Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 2Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 3Health News:Xarelto Lawsuit News: Bernstein Liebhard LLP Comments on Growing Use of Xarelto in Spite of Mounting Product Liability Litigation 4Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:Complication Rates Low With Mastectomy, Breast Reconstruction: Study 2
... seen with cirrohosis but aren,t sensitive enough , , ... to detect esophageal bleeding in people with cirrhosis show ... researchers. , About 25 percent of patients with cirrhosis ... veins commonly seen with cirrhosis. Variceal bleeding can cause ...
... movement, serious complications can follow, experts note , , TUESDAY, ... identified a marker that might predict which pregnant women ... essentially a baby,s first bowel movement, excreted in the ... is considered a sign of fetal distress. A small ...
... London, New Delhi, and Singapore (6 May, 2008) ... manage patients with depression has challenged the rationale behind ... behavioural therapy (CBT) for milder depression. , According ... is a lack of evidence for CBT being more ...
... with state and local public health agencies for,Community ... The Community Coalitions Health,Institute (CCHI), a 501(c)(3) affiliate ... that it has received a five-year grant from ... improvement in,community health systems across the country. The ...
... WHAT: On national grassroots lobby day, Lance Armstrong to visit four ... * TUESDAY, MAY 13, 2008 WHERE: Tour of Ralph ... (RLC) and RLC Fifth Anniversary Celebration at the Marcus ... 1919 Madison Avenue (Entrance on 124th Street) ...
... WASHINGTON, May 6 The latest,"gaming for health" ... games (e.g., a "disease" being unleashed inadvertently,on the ... videogames,used to train emergency medical personnel -- will ... event at 1 p.m. EDT Thursday,(May 8, 2008)., ...
Cached Medicine News:Health News:Noninvasive Procedures Show Promise for Esophageal Bleeding 2Health News:Doctors Discover Marker for Meconium Passage During Delivery 2Health News:Antidepressants do work in depression while evidence for CBT is poorer say experts 2Health News:Antidepressants do work in depression while evidence for CBT is poorer say experts 3Health News:NBCH's Community Coalitions Health Institute Receives CDC Grant 2Health News:Lance Armstrong Marks 5th Annual LIVESTRONG(TM) Day with Nationwide Fly-Around 2Health News:Video Gaming for Health: Major New Trends to Be Discussed as National Conference Gets Underway 2
(Date:9/2/2014)... 2, 2014  Numotion is pleased to announce the appointment ... Directors. Mark is a 30-year retired veteran ... across the organization and was a GE Company Officer since ... spent many years running business units within GE Healthcare, with ... Americas. "We are delighted to welcome Mark ...
(Date:9/2/2014)... 2014  On July 31, the Food and Drug ... is moving forward to regulate laboratory-developed tests (LDTs). The ... throughout the U.S. will need to comply with a ... laboratories may subscribe to the strategy to simply sit ... in place, it,s widely acknowledged that failure to answer ...
(Date:9/2/2014)... YORK , Sept. 2, 2014 ... is available in its catalogue: ... http://www.reportlinker.com/p02353210/Asia-Pacific-Infusion-Therapy-Device-Market.html Abstract: ... infusion therapy devices included volumetric infusion pumps, syringe ... needleless connectors and stopcocks. These categories are segmented ...
Breaking Medicine Technology:FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply 2FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply 3Asia-Pacific Infusion Therapy Device Market 2Asia-Pacific Infusion Therapy Device Market 3Asia-Pacific Infusion Therapy Device Market 4Asia-Pacific Infusion Therapy Device Market 5Asia-Pacific Infusion Therapy Device Market 6Asia-Pacific Infusion Therapy Device Market 7Asia-Pacific Infusion Therapy Device Market 8Asia-Pacific Infusion Therapy Device Market 9Asia-Pacific Infusion Therapy Device Market 10Asia-Pacific Infusion Therapy Device Market 11Asia-Pacific Infusion Therapy Device Market 12Asia-Pacific Infusion Therapy Device Market 13Asia-Pacific Infusion Therapy Device Market 14
... Society of Clinical Oncology,s ... Genitourinary Symposium -, ... (Nasdaq: DNDN ) today presented data,demonstrating the correlation of ... active cellular immunotherapy,for hormone-refractory prostate cancer, with overall survival. This ...
... Confirm the Benefit Avastin Brings to ... Patients With Breast Cancer., BASEL, ... in metastatic breast cancer investigating Avastin,(bevacizumab) in combination with docetaxel chemotherapy ... patients,live without their disease advancing., The findings come from the ...
Cached Medicine Technology:Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival 2Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival 3Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival 4Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 2Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint 3
The Triage® Parasite Panel is an enzyme immunoassay used for the detection of antigens specific for Giardia lamblia, Entamoeba histolytica/dispar and Cryptosporidium parvum in fresh or freshly fr...
... Urostym™ provides the most current ... including urinary and fecal incontinence. ... easily providing complete patient information ... Customer testimonials have proven Urostym™ ...
... affordable path to Sonesta flexibility. Three ... back adjustments. Packaged with basic accessories, ... of Sonesta add-ons, allowing you to ... needs; complete Sonesta flexibility at an ...
The Triage Drugs of Abuse Panel is the leading rapid drug screen used by U.S. hospitals. The Triage Drugs of Abuse Panel is a small, handheld urine test that provides qualitative results for up to n...
Medicine Products: